Clinical Trial Update: Sublingual Administration of PPI

View source ↗

Summary

A clinical trial is evaluating sublingual administration of a proton pump inhibitor for gastric or duodenal ulcers; the status of the study is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• PPI Sublingual Formulation (proton pump inhibitor)

Snippet

Sponsor: The Catholic University of Korea | Conditions: Gastric or Duodenal Ulcer | Status: UNKNOWN